Internal Medicine · Philadelphia, PA
NPI
1033150800
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
7600 Central Ave
Philadelphia, PA, 19111
Phone (215) 728-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
727 services
Medicare patients, 2024
99
Average age 62
Drug cost, 2024
$1.1M
14,209 prescriptions
Company payments, 2025
$177
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fabian A Vengoechea was code 99213 (office e&m - established), 365 times for 76 patients. In total Fabian A Vengoechea billed 727 services in 7 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 365 | 76 | $46.81 | $17K |
| 99214 Office E&M - Established | Office | 243 | 58 | $75.26 | $18K |
| 90833 Psychotherapy - Nongroup | Office | 45 | 26 | $51.61 | $2,323 |
| 99204 Office E&M - New | Office | 27 | 27 | $104.78 | $2,829 |
| 99491 Chronic, Principal, and Transitional Care Management | Office | 24 | 24 | $63.40 | $1,522 |
| 99437 Chronic, Principal, and Transitional Care Management | Office | 22 | 22 | $46.46 | $1,022 |
By year: 2022 $26K for 471 services; 2023 $40K for 602 services; 2024 $43K for 727 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fabian A Vengoechea prescribed most often to Medicare patients was Atorvastatin Calcium, with 948 prescriptions and refills. In total Fabian A Vengoechea wrote 14,209 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 948 | 1,113 | 122 | $6,507 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 597 | 618 | 111 | $17K |
| Omeprazole Generic | 527 | 563 | 68 | $3,801 |
| Gabapentin Generic | 484 | 506 | 60 | $3,856 |
| Lisinopril Generic | 465 | 571 | 69 | $1,613 |
| Ibuprofen Generic | 400 | 400 | 70 | $1,752 |
| Amlodipine Besylate Generic | 395 | 461 | 55 | $1,828 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 383 | 383 | 43 | $70K |
| Carvedilol Generic | 321 | 350 | 38 | $1,679 |
| Endocet Oxycodone Hcl/Acetaminophen | 284 | 284 | 30 | $3,798 |
| Metformin Hcl Generic | 281 | 329 | 39 | $869 |
| Losartan Potassium Generic | 276 | 341 | 38 | $1,972 |
| Pantoprazole Sodium Generic | 265 | 311 | 38 | $1,674 |
| Clonazepam Generic | 263 | 263 | 33 | $1,842 |
| Alprazolam Generic | 249 | 249 | 30 | $1,062 |
Brand drugs: 2,070 claims; generic drugs: 11,862 claims; opioid claims: 878.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fabian A Vengoechea $177 ($177 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $177.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 9 | $177 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.